Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NINDS investigates SGS-742 in phase II trial for SSADH deficiency

Jan. 2, 2014

Danish group patents new GPR120 ligands

Dec. 31, 2013

VHRI and Grifols collaborate to create center of excellence in alpha-1-antitrypsin deficiency

Dec. 31, 2013

Genzyme evaluates rhASM in new phase II trials for ASD

Dec. 31, 2013

Swedish Orphan Biovitrum temporarily withdraws NDA for Orfadin

Dec. 30, 2013

Takeda stops development of fasiglifam

Dec. 30, 2013

Kissei grants Pfizer development and commercialization rights for KUX-1151

Dec. 30, 2013

Antisense Therapeutics reports data from interim analysis of ATL-1103

Dec. 30, 2013

Resverlogix completes enrollment in phase II trial of RVX-208

Dec. 30, 2013

FDA issues CRL for Actavis' progestin-only transdermal contraceptive patch

Dec. 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...